Literature DB >> 8359159

Increasing problems in the therapy of enterococcal infections.

G M Eliopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8359159     DOI： 10.1007/bf01967433

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  34 in total

1.  In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A).

Authors:  B P Goldstein; M Berti; F Ripamonti; A Resconi; R Scotti; M Denaro
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

2.  Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.

Authors:  R G Hindes; S H Willey; G M Eliopoulos; L B Rice; C T Eliopoulos; B E Murray; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

3.  Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward.

Authors:  E Rhinehart; N E Smith; C Wennersten; E Gorss; J Freeman; G M Eliopoulos; R C Moellering; D A Goldmann
Journal:  N Engl J Med       Date:  1990-12-27       Impact factor: 91.245

Review 4.  Therapy of enterococcal infections.

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

5.  beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.

Authors:  M Ingerman; P G Pitsakis; A Rosenberg; M T Hessen; E Abrutyn; B E Murray; M E Levison
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

6.  Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance.

Authors:  M L Grayson; G M Eliopoulos; C B Wennersten; K L Ruoff; K Klimm; F L Sapico; A S Bayer; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

7.  Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis.

Authors:  L B Rice; G M Eliopoulos; C Wennersten; D Goldmann; G A Jacoby; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

8.  Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031.

Authors:  S L Hodel-Christian; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.

Authors:  M Arthur; C Molinas; F Depardieu; P Courvalin
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

10.  The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanC.

Authors:  S Evers; D F Sahm; P Courvalin
Journal:  Gene       Date:  1993-02-14       Impact factor: 3.688
View more
  15 in total

1.  Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones.

Authors:  S Brisse; A C Fluit; U Wagner; P Heisig; D Milatovic; J Verhoef; S Scheuring; K Köhrer; F J Schmitz
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Survey of antibiotic resistance among enterococci in North Rhine-Westphalia, Germany.

Authors:  R R Reinert; G Conrads; J J Schlaeger; G Werner; W Witte; R Lütticken; I Klare
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 3.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

4.  Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis.

Authors:  D B Hoellman; G Lin; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

5.  Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.

Authors:  D B Hoellman; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

6.  Survey of enterococcal susceptibility patterns in Belgium.

Authors:  P Vandamme; E Vercauteren; C Lammens; N Pensart; M Ieven; B Pot; R Leclercq; H Goossens
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Neonatal bacteremia due to high level aminoglycoside resistant (HLAR) enterococci.

Authors:  K G Bhat; C Paul; M G Bhat
Journal:  Indian J Pediatr       Date:  1997 Jul-Aug       Impact factor: 1.967

8.  Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.

Authors:  G S Perdikaris; A Pefanis; H Giamarellou; A Nikolopoulos; E P Margaris; I Donta; A Tsitsika; P Karayiannakos
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

9.  Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients.

Authors:  M Ieven; E Vercauteren; P Descheemaeker; F van Laer; H Goossens
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

10.  In vitro activities of two glycylcyclines against gram-positive bacteria.

Authors:  G M Eliopoulos; C B Wennersten; G Cole; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.